Characteristics | Nb (%) |
---|---|
Sex | |
Male (%) | 18 (64) |
Female (%) | 10 (36) |
Age (median, range), years | 63 (42–79) |
Tobacco use (%) | 23 (82) |
Histologya | |
Adenocarcinoma (%) | 21 (75) |
Squamous cell carcinoma (%) | 4 (14) |
Large cell carcinoma (%) | 1 (4) |
Large cell neuroendocrine carcinoma (%) | 1 (4) |
Lymphoepithelioma-like carcinoma (%) | 1 (4) |
Previous lines of chemotherapy (median, range) | 2 (1–5) |
Previous thoracic surgery | 5 (18) |
No. of nivolumab cycles (median, range) | 11 (4–27) |